Altor BioScience names new business head
This article was originally published in Scrip
Altor Bioscience, a privately held biotechnology company developing immunotherapies for treating cancer, viral infections, and inflammatory diseases, has named Kevin Taylor chief business officer. He will report to CEO Dr Hing C Wong. Prior to joining Altor, Mr Taylor was chief business officer at Nuron Biotech.